FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Klaus Fassbender

Research Profile

Anatomy

Living Beings

Mouse

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

X Ray Computed Tomography

Physiology

Blood-Brain Barrier

Co-author Network

Publications

TOP 3
Klaus Fassbender; Anton Haass; Steven R Levine; Silke Walter; Clotilde Balucani; James Grotta
Streamlining of prehospital stroke management: the golden hour.
Christian Roth; J Viera; Silke Walter; Umut Yilmaz; Maria Politi; Wolfgang Reith; Maria Alexandrou; Stefanie Behnke; Klaus Fassbender; Anton Haass; Michael Kettner; Heiko Körner; Panagiotis Kostopoulos; Christoph Krick; Panagiotis Papanagiotou
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke: The ReFlow (Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke) Study.
Yang Liu; Ivan Mihaljevic; Silke Walter; Kan Xie; Min Zhang; Wenlin Hao; Xu Liu; Klaus Fassbender
Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Klaus Fassbender (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Klaus Fassbender; Anton Haass; Steven R Levine; Silke Walter; Clotilde Balucani; James Grotta
Streamlining of prehospital stroke management: the golden hour.
Lancet neurology 2013;12(6):585-96.
2013: Christian Roth; J Viera; Silke Walter; Umut Yilmaz; Maria Politi; Wolfgang Reith; Maria Alexandrou; Stefanie Behnke; Klaus Fassbender; Anton Haass; Michael Kettner; Heiko Körner; Panagiotis Kostopoulos; Christoph Krick; Panagiotis Papanagiotou
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke: The ReFlow (Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke) Study.
JACC. Cardiovascular interventions 2013;6(4):386-91.
2013: Yang Liu; Ivan Mihaljevic; Silke Walter; Kan Xie; Min Zhang; Wenlin Hao; Xu Liu; Klaus Fassbender
Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain.
Neurobiology of aging 2013;34(4):1231-9.
2013: Stefanie Behnke; Ulrich Dillmann; Klaus Fassbender; Daniel Guidez; Hadia Al-Sibai Kassar; Mirjam Ortmann; Anne Runkel; Jörg Spiegel
Long-term course of substantia nigra hyperechogenicity in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2013;28(4):455-9.
2013: Daniela Berg; Kathrin Brockmann; Klaus Fassbender; Alexandra Gaenslen; Arno Gasperi; Thomas Gasser; Jana Godau; Heiko Huber; Stefan Kiechl; Stefanie Lerche; Inga Liepelt-Scarfone; Philipp Mahlknecht; Christoph Pausch; Niko Schneider; Klaus Seppi; Karin Srulijes; Heike Stockner; Johann Willeit; Isabel Wurster; Stefanie Behnke; Werner Poewe
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2013;28(2):216-9.
2013: Laura Davies; Klaus Fassbender; Silke Walter
Sphingolipids in neuroinflammation.
Handbook of experimental pharmacology 2013;216():421-30.
2013: Daniela Berg; Klaus Fassbender; A Gaenslen; J Godau; H Huber; Jochen Klenk; S Lerche; I Liepelt-Scarfone; Walter Maetzler; P Mahlknecht; Werner Poewe; Klaus Seppi; K Srulijes; Heike Stockner; Stefanie Behnke
The PRIPS study: screening battery for subjects at risk for Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2013;20(1):102-8.
2012: Kurt-Wolfram Sühs; Mathias Bähr; Diana Bittersohl; Christoph Ciupka; Klaus Fassbender; Anke Görlitz; Andrea Hassenstein; Christoph Heesen; Katharina Hein; Reinhard Hilgers; Barbara Käsmann-Kellner; Panagiotis Papanagiotou; Wolfgang Reith; Cordula Restemeyer; Muriel B Sättler; Nina Schäffler; Kerstin Scholz; Berthold Seitz; Ricarda Diem
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Annals of neurology 2012;72(2):199-210.
2012: Panagiotis Papanagiotou; Klaus Fassbender; Anton Haass; Christian Roth; Silke Walter; Wolfgang Reith
Angiographic evidence of reperfusion injury after carotid artery stenting.
Journal of the American College of Cardiology 2012;60(5):e7.
2012: Manuela Gries; Tobias Hartmann; Yang Liu; Jörg Spiegel; Armin Bachhuber; Laura Davies; Ulrich Dillmann; Klaus Fassbender; Silke Walter
Response of Toll-like receptors in experimental Guillain-Barré syndrome: a kinetic analysis.
Neuroscience letters 2012;518(2):154-60.
2012: Silke Walter; Umut Yilmaz; Karin Ziegler; Maria Alexandrou; Thomas Bertsch; Rainer Dabew; Iris Quasar Grunwald; Anton Haass; Stephan Helwig; Isabel Keller; Heiko Körner; Panagiotis Kostopoulos; Kai Kronfeld; Darius Kubulus; Martin Lesmeister; Yang Liu; Panagiotis Papanagiotou; Wolfgang Reith; Christian Roth; Christian Ruckes; Thomas Schlechtriemen; Kathrin Schmidt; Helmut Schumacher; J Viera; Thomas Volk; Klaus Fassbender
Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial.
Lancet neurology 2012;11(5):397-404.
2012: Shirong Liu; Yang Liu; Michael D Menger; Botond Penke; Claudia E Rübe; Jochen Walter; Lisa Wolf; Wenlin Hao; Tobias Hartmann; Michael T Heneka; Amanda J Kiliaan; Klaus Fassbender
TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(3):1098-107.
2011: Panagiotis Papanagiotou; Maria Politi; Christian Roth; J Viera; Silke Walter; Stefanie Behnke; Klaus Fassbender; Iris Quasar Grunwald; Anton Haass; Heiko Körner; Panagiotis Kostopoulos; Wolfgang Reith
Carotid artery stenting in acute stroke.
Journal of the American College of Cardiology 2011;58(23):2363-9.
2011: Daniela Berg; Klaus Fassbender; Alexandra Gaenslen; Arno Gasperi; Thomas Gasser; Jana Godau; Teresa Hiry; Heiko Huber; Stefan Kiechl; Jochen Klenk; Inga Liepelt; Walter Maetzler; Philipp Mahlknecht; Mareike Probst; Martin Sawires; Vera Schneider; Teresa Schubert; Katherine Schweitzer; Klaus Seppi; Jörg Spiegel; Karin Srulijes; Heike Stockner; Johann Willeit; Frank Wollenweber; Stefanie Behnke; Marianna Bentele; Werner Poewe
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.
Archives of neurology 2011;68(7):932-7.
2011: Julia Dorschner; Georgios Farmakis; Stefanie Behnke; Dirk Hellwig; Susanne Schneider; Klaus Fassbender; Carl-Martin Kirsch; Ulrich Dillmann; Jörg Spiegel
Myocardial MIBG scintigraphy may predict the course of motor symptoms in Parkinson's disease.
Parkinsonism & related disorders 2011;17(5):372-5.
2011: Robert Schomburg; Daniela Remane; Klaus Fassbender; Hans H Maurer; Jörg Spiegel
Doxepin concentrations in plasma and cerebrospinal fluid.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(4):641-5.
2011: Frank Arne Wollenweber; Robert Schomburg; Mareike Probst; Vera Schneider; Teresa Hiry; Annika Ochsenfeld; Martin Mueller; Ulrich Dillmann; Klaus Fassbender; Stefanie Behnke
Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time- and cost-effective manner--results from a longitudinal study on 500 subjects.
Psychiatry research 2011;191(3):212-6.
2011: Silke Walter; Panagiotis Kostopoulos; A Haass; Martin Lesmeister; Mihaela Grasu; Iris Quasar Grunwald; Isabel Keller; Stephan Helwig; Carmen Becker; Juergen Geisel; Thomas Bertsch; Sarah Kaffiné; Annika Leingärtner; Panagiotis Papanagiotou; Christian Roth; Yang Liu; Wolfgang Reith; Klaus Fassbender
Point-of-care laboratory halves door-to-therapy-decision time in acute stroke.
Annals of neurology 2011;69(3):581-6.
2011: Marcus Otto Walter Grimm; Sven Grösgen; Verena K Burg; Klaus Fassbender; Petra Friess; Heike S Grimm; Viola J Haupenthal; Benjamin Hundsdörfer; Ulrike Müller; Matthias Riemenschneider; Tatjana L Rothhaar; Tobias Hartmann
Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease.
International journal of Alzheimer's disease 2011;2011():695413.
2011: Magdalena Hubbuch; Georgios Farmakis; Andrea Schaefer; Stefanie Behnke; Susanne Schneider; Dirk Hellwig; Klaus Fassbender; Carl-Martin Kirsch; Ulrich Dillmann; Jörg Spiegel
FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson's disease.
European neurology 2011;65(4):187-92.
2011: Wenlin Hao; Yang Liu; Shirong Liu; Silke Walter; Marcus Otto Walter Grimm; Amanda J Kiliaan; Botond Penke; Tobias Hartmann; Claudia E Rübe; Michael D Menger; Klaus Fassbender
Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Brain : a journal of neurology 2011;134(Pt 1):278-92.
2010: Christian Roth; Panagiotis Papanagiotou; S Behnke; Silke Walter; A Haass; C Becker; Klaus Fassbender; M Politi; H Körner; M-S Romann; Wolfgang Reith
Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions.
Stroke; a journal of cerebral circulation 2010;41(11):2559-67.
2010: Panagiotis Papanagiotou; Christian Roth; Silke Walter; Stefanie Behnke; Maria Politi; Klaus Fassbender; Anton Haass; Wolfgang Reith
Treatment of acute cerebral artery occlusion with a fully recoverable intracranial stent: a new technique.
Circulation 2010;121(23):2605-6.
2010: Silke Walter; Panagiotis Kostpopoulos; Anton Haass; Stefan Helwig; Isabel Keller; Tamara Licina; Thomas Schlechtriemen; Christian Roth; Panagiotis Papanagiotou; Anna Zimmer; Julio Vierra; Heiko Körner; Kathrin Schmidt; Marie-Sophie Romann; Maria Alexandrou; Umut Yilmaz; Iris Quasar Grunwald; Darius Kubulus; Martin Lesmeister; Stephan Ziegeler; Alexander Pattar; Martin Golinski; Yang Liu; Thomas Volk; Thomas Bertsch; Wolfgang Reith; Julio Viera; Klaus Fassbender
Bringing the hospital to the patient: first treatment of stroke patients at the emergency site.
PloS one 2010;5(10):e13758.
2010: Silke Walter; Klaus Fassbender
Spingolipids in Multiple Sclerosis.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2010;26(1):49-56.
2009: Rima Obeid; Achim Schadt; Ulrich Dillmann; Panagiotis Kostopoulos; Klaus Fassbender; Wolfgang Herrmann
Methylation status and neurodegenerative markers in Parkinson disease.
Clinical chemistry 2009;55(10):1852-60.
2009: Maryse Letiembre; Yang Liu; Silke Walter; Wenlin Hao; Tatjana Pfander; Arne Wrede; Walter Schulz-Schaeffer; Klaus Fassbender
Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
Neurobiology of aging 2009;30(5):759-68.
2009: Yang Liu; Wenlin Hao; Alik Dawson; Shirong Liu; Klaus Fassbender
Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2.
The Journal of biological chemistry 2009;284(6):3691-9.
2007: Maryse Letiembre; Wenlin Hao; Yang Liu; Silke Walter; I Mihaljevic; Serge Rivest; Tobias Hartmann; Klaus Fassbender
Innate immune receptor expression in normal brain aging.
Neuroscience 2007;146(1):248-54.
2007: Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2007;20(6):947-56.
2006: Yang Liu; Wenlin Hao; Maryse Letiembre; Silke Walter; Miroslav Kulanga; Harald Neumann; Klaus Fassbender
Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(50):12904-13.
2006: Mark Stroick; Marc Fatar; Andreas Ragoschke-Schumm; Klaus Fassbender; Thomas Bertsch; Michael G Hennerici
Protein S-100B--a prognostic marker for cerebral damage.
Current medicinal chemistry 2006;13(25):3053-60.
2006: Silke Walter; Axinia Doering; Maryse Letiembre; Yang Liu; Wenlin Hao; Ricarda Diem; Christian Bernreuther; Markus Glatzel; Britta Engelhardt; Klaus Fassbender
The LPS receptor, CD14, in experimental autoimmune encephalomyelitis and multiple sclerosis.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2006;17(3-4):167-72.
2005: Yang Liu; Silke Walter; Massimiliano Stagi; Dmitry Cherny; Maryse Letiembre; Walter Schulz-Schaeffer; Holger Heine; Botond Penke; Harald Neumann; Klaus Fassbender
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
Brain : a journal of neurology 2005;128(Pt 8):1778-89.
2004: Dieter Lütjohann; Mark Stroick; Thomas Bertsch; Sandra Kühl; Bernhard Lindenthal; Karin M Thelen; Ulla Andersson; Ingemar Björkhem; Klaus von Bergmann Kv; Klaus Fassbender
High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs.
Steroids 2004;69(6):431-8.
2004: Klaus Fassbender; Silke Walter; Sandra Kühl; Regine Landmann; K Ishii; Thomas Bertsch; Anna K Stalder; Frank Muehlhauser; Yang Liu; Artur J Ulmer; Serge Rivest; Arnd Lentschat; E Gulbins; Mathias Jucker; Matthias Staufenbiel; Katrin Brechtel; J Walter; Gerd Multhaup; Botond Penke; Y Adachi; Tobias Hartmann; Konrad Beyreuther
The LPS receptor (CD14) links innate immunity with Alzheimer's disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(1):203-5.
2003: Paul Lingor; Dirk von Boetticher; Mathias Bähr; Klaus Fassbender
Paraneoplastic polymyositis in recurring adrenal gland carcinoma.
Lancet neurology 2003;2(7):435-6.
2003: Klaus Fassbender; Silke Walter; Yang Liu; Frank Muehlhauser; Andreas Ragoschke; Sandra Kuehl; Orell Mielke
"Mobile stroke unit" for hyperacute stroke treatment.
Stroke; a journal of cerebral circulation 2003;34(6):e44.
2002: Silke Walter; Klaus Fassbender; Erich Gulbins; Yang Liu; Monika Rieschel; Monika Herten; Thomas Bertsch; Britta Engelhardt
Glycosylation processing inhibition by castanospermine prevents experimental autoimmune encephalomyelitis by interference with IL-2 receptor signal transduction.
Journal of neuroimmunology 2002;132(1-2):1-10.
2002: Klaus Fassbender; Mark Stroick; Thomas Bertsch; Andreas Ragoschke; Sandra Kuehl; Silke Walter; J Walter; Katrin Brechtel; Frank Muehlhauser; Klaus Von Bergmann; Dieter Lütjohann
Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide.
Neurology 2002;59(8):1257-8.
2002: Bernhard Lindenthal; Thomas Bertsch; Klaus Fassbender; Mark Stroick; Sandra Kühl; Dieter Lütjohann; Klaus Von Bergmann
Influence of simvastatin, pravastatin, and BM 15.766 on neutral sterols in liver and testis of guinea pigs.
Metabolism: clinical and experimental 2002;51(4):492-9.
2002: Johannes Aufenanger; Michael Samman; Michael Quintel; Klaus Fassbender; Wilma Zimmer; Thomas Bertsch
Pancreatic phospholipase A2 activity in acute pancreatitis: a prognostic marker for early identification of patients at risk.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2002;40(3):293-7.
2002: Klaus Fassbender; Andreas Ragoschke; Sandra Kühl; Kristina Szabo; Marc Fatar; Walter Back; Thomas Bertsch; Stefan Kreisel; Michael Hennerici
Inflammatory leukocyte infiltration in focal cerebral ischemia: unrelated to infarct size.
Cerebrovascular diseases (Basel, Switzerland) 2002;13(3):198-203.
2001: Thomas Bertsch; Orell Mielke; S Höly; Wilma Zimmer; W Casarin; Johannes Aufenanger; S Walter; Frank Muehlhauser; Sandra Kuehl; Andreas Ragoschke; Klaus Fassbender
Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(8):721-4.
2001: Klaus Fassbender; M Simons; C Bergmann; Mark Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; Thomas Bertsch; Klaus Von Bergmann; Michael Hennerici; Konrad Beyreuther; Tobias Hartmann
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(10):5856-61.
2001: Thomas Bertsch; Sandra Kuehl; Frank Muehlhauser; S Walter; B Hodapp; S Rossol; Joachim Schmeck; Andreas Ragoschke; S Schütt; M Fritzinger; Peter Horn; Peter Vajkoczy; M W Wellner; Klaus Fassbender
Source of endothelin-1 in subarachnoid hemorrhage.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(4):341-5.
2001: Thomas Bertsch; W Casarin; Marianne Kretschmar; Wilma Zimmer; S Walter; C Sommer; Frank Muehlhauser; Andreas Ragoschke; Sandra Kuehl; R Schmidt; B P Eden; C Nassabi; Thomas Nichterlein; Klaus Fassbender
Protein S-100B: a serum marker for ischemic and infectious injury of cerebral tissue.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(4):319-23.
2001: Frank Muehlhauser; U Liebl; Sandra Kuehl; S Walter; Thomas Bertsch; Klaus Fassbender
Aggregation-Dependent interaction of the Alzheimer's beta-amyloid and microglia.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(4):313-6.
2001: Klaus Fassbender; B Hodapp; S Rossol; Thomas Bertsch; Joachim Schmeck; S Schütt; M Fritzinger; Peter Horn; Peter Vajkoczy; Stefan Kreisel; J Brunner; P Schmiedek; Michael Hennerici
Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries.
Journal of neurology, neurosurgery, and psychiatry 2001;70(4):534-7.
2000: Klaus Fassbender; B Hodapp; S Rossol; Thomas Bertsch; Joachim Schmeck; S Schütt; M Fritzinger; Peter Horn; Peter Vajkoczy; Martina Wendel-Wellner; Andreas Ragoschke; Sandra Kuehl; J Brunner; L Schürer; P Schmiedeck; Michael Hennerici
Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes.
Stroke; a journal of cerebral circulation 2000;31(12):2971-5.
2000: Klaus Fassbender; Marc Fatar; Andreas Ragoschke; M Picard; Thomas Bertsch; Sandra Kuehl; Michael Hennerici
Subacute but not acute generation of nitric oxide in focal cerebral ischemia.
Stroke; a journal of cerebral circulation 2000;31(9):2208-11.
2000: K Ishii; F Muelhauser; U Liebl; M Picard; Sandra Kühl; Botond Penke; Thomas A Bayer; M Wiessler; Michael Hennerici; Konrad Beyreuther; Tobias Hartmann; Klaus Fassbender
Subacute NO generation induced by Alzheimer's beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(11):1485-9.
2000: Klaus Fassbender; S Schneider; Thomas Bertsch; D Schlueter; Marc Fatar; Andreas Ragoschke; Sandra Kühl; U Kischka; Michael Hennerici
Temporal profile of release of interleukin-1beta in neurotrauma.
Neuroscience letters 2000;284(3):135-8.
1999: Klaus Fassbender; S Kaptur; P Becker; J Gröschel; R Schmidt; Michael Hennerici
Inverse association between endogenous glucocorticoid secretion and L-selectin (CD62L) expression in trauma patients.
Life sciences 1999;65(23):2471-80.
1999: Klaus Fassbender; Orell Mielke; Michael Hennerici; Thomas Bertsch
Plasma homocyst(e)ine concentrations in cerebrovascular disease.
Stroke; a journal of cerebral circulation 1999;30(10):2244-5.
1999: Klaus Fassbender; C E Dempfle; Orell Mielke; A Schwartz; Michael Daffertshofer; Christoph Eschenfelder; M Dollman; Michael Hennerici
Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator.
Stroke; a journal of cerebral circulation 1999;30(10):2101-4.
1999: Klaus Fassbender; Orell Mielke; Thomas Bertsch; Frank Muehlhauser; Michael Hennerici; M Kurimoto; S Rossol
Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases.
Neurology 1999;53(5):1104-6.
1999: Klaus Fassbender; Thomas Bertsch; Orell Mielke; F Mühlhauser; Michael Hennerici
Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease.
Stroke; a journal of cerebral circulation 1999;30(8):1647-50.
1999: Klaus Fassbender; Orell Mielke; Thomas Bertsch; B Nafe; S Fröschen; Michael Hennerici
Homocysteine in cerebral macroangiography and microangiopathy.
Lancet 1999;353(9164):1586-7.
1999: Klaus Fassbender; Christoph Eschenfelder; Michael Hennerici
Fas (APO-1/CD95) in inflammatory CNS diseases: intrathecal release in bacterial meningitis.
Journal of neuroimmunology 1999;93(1-2):122-5.
1999: J Knauber; U Kischka; M Roth; W J Schmidt; Michael Hennerici; Klaus Fassbender
Modulation of striatal acetylcholine concentrations by NMDA and the competitive NMDA receptor-antagonist AP-5: an in vivo microdialysis study.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(1):35-45.
1998: Klaus Fassbender; S Kaptur; P Becker; J Gröschl; M Hennerici
Adhesion molecules in tissue injury: kinetics of expression and shedding and association with cytokine release in humans.
Clinical immunology and immunopathology 1998;89(1):54-60.
1998: Klaus Fassbender; Andreas Ragoschke; S Rossol; A Schwartz; Orell Mielke; A Paulig; Michael Hennerici
Increased release of interleukin-12p40 in MS: association with intracerebral inflammation.
Neurology 1998;51(3):753-8.
1998: Klaus Fassbender; R Schmidt; R Mössner; U Kischka; J Kühnen; A Schwartz; Michael Hennerici
Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.
Archives of neurology 1998;55(1):66-72.
1997: Klaus Fassbender; C E Dempfle; Orell Mielke; S Rossol; S Schneider; M Dollman; Michael Hennerici
Proinflammatory cytokines: indicators of infection in high-risk patients.
The Journal of laboratory and clinical medicine 1997;130(5):535-9.
1997: Klaus Fassbender; R Schmidt; A Schreiner; Marc Fatar; F Mühlhauser; Michael Daffertshofer; Michael Hennerici
Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.
Journal of the neurological sciences 1997;148(1):101-5.
1997: Klaus Fassbender; U Schminke; Stefan Ries; Andreas Ragoschke; U Kischka; Marc Fatar; Michael Hennerici
Endothelial-derived adhesion molecules in bacterial meningitis: association to cytokine release and intrathecal leukocyte-recruitment.
Journal of neuroimmunology 1997;74(1-2):130-4.
1997: Stefan Ries; U Schminke; Klaus Fassbender; Michael Daffertshofer; W Steinke; Michael Hennerici
Cerebrovascular involvement in the acute phase of bacterial meningitis.
Journal of neurology 1997;244(1):51-5.
1996: Klaus Fassbender; Stefan Ries; U Schminke; S Schneider; M Hennerici
Inflammatory cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal cerebral arteries.
Journal of neurology, neurosurgery, and psychiatry 1996;61(1):57-61.
1996: R Mössner; Klaus Fassbender; J Kühnen; A Schwartz; M Hennerici
Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques.
Journal of neuroimmunology 1996;65(1):61-5.
1996: R Mössner; Klaus Fassbender; J Kühnen; A Schwartz; M Hennerici
Vascular cell adhesion molecule--a new approach to detect endothelial cell activation in MS and encephalitis in vivo.
Acta neurologica Scandinavica 1996;93(2-3):118-22.
1995: Klaus Fassbender; R Mössner; L Motsch; U Kischka; A Grau; M Hennerici
Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke.
Stroke; a journal of cerebral circulation 1995;26(8):1361-4.
1994: Klaus Fassbender; R Schmidt; R Mössner; Michael Daffertshofer; M Hennerici
Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome.
Stroke; a journal of cerebral circulation 1994;25(6):1105-8.
1994: Klaus Fassbender; S Rossol; T Kammer; Michael Daffertshofer; S Wirth; M Dollman; M Hennerici
Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease.
Journal of the neurological sciences 1994;122(2):135-9.